Literature DB >> 8011822

Mycobacterium kansasii among patients infected with human immunodeficiency virus in Kansas City. Kansas City AIDS Research Consortium.

D M Bamberger1, M R Driks, M R Gupta, M C O'Connor, P M Jost, R E Neihart, D S McKinsey, L A Moore.   

Abstract

Previous reports of infection due to Mycobacterium kansasii among patients infected with human immunodeficiency virus (HIV) have conflicted with regard to the significance of the isolate; the clinical, radiographic, and laboratory features of the disease; and the response to therapy. To clarify the spectrum of M. kansasii infection in this population, we conducted a retrospective study of 35 patients. Twenty-eight of these patients were believed to have disease due to M. kansasii, while the remaining seven patients were probably colonized with the organism. All but two patients presented with advanced HIV infection; the median CD4 cell count was 12/microL. Most patients with pulmonary disease presented with fever, cough, and dyspnea, but only eight of these 22 patients had radiographic findings of either pulmonary cavitation or predominantly upper-lobe disease. Ten patients had M. kansasii isolated from blood or bone marrow. The majority of patients with pulmonary or disseminated disease responded to therapy. However, 11 patients died either before mycobacterial infection was diagnosed or early in the course of treatment, and two had a relapse of infection during therapy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8011822     DOI: 10.1093/clinids/18.3.395

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  4 in total

1.  Management of opportunist mycobacterial infections: Joint Tuberculosis Committee Guidelines 1999. Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society.

Authors: 
Journal:  Thorax       Date:  2000-03       Impact factor: 9.139

2.  Clinical implications of Mycobacterium kansasii species heterogeneity: Swiss National Survey.

Authors:  Caroline Taillard; Gilbert Greub; Rainer Weber; Gaby E Pfyffer; Thomas Bodmer; Stefan Zimmerli; Reno Frei; Stefano Bassetti; Peter Rohner; Jean-Claude Piffaretti; Enos Bernasconi; Jacques Bille; Amalio Telenti; Guy Prod'hom
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

3.  Mycobacterium kansasii: its presentation, treatment and outcome in HIV infected patients.

Authors:  G Rooney; M R Nelson; B Gazzard
Journal:  J Clin Pathol       Date:  1996-10       Impact factor: 3.411

4.  Clinical and Microbiological Characteristics of Mycobacterium kansasii Pulmonary Infections in China.

Authors:  Yinjuan Guo; Yanhua Cao; Haican Liu; Jinghui Yang; Weiping Wang; Bingjie Wang; Meilan Li; Fangyou Yu
Journal:  Microbiol Spectr       Date:  2022-01-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.